Anemia and hypertension are risk factors for both renal prognosis and survival in patients with diabetes mellitus

Clinical and Experimental Nephrology

Volumn 13, Issue 5, 2009, Pages 473-479

  Sasatomi, Yoshie ^a   Kaneoka, Hidetoshi ^a   Abe, Yasuhiro ^a   Ishimura, Atunori ^a   Ogahara, Satoru ^a   Murata, Toshiaki ^a   Uesugi, Noriko ^b   Takebayashi, Shigeo ^b   Iwasaki, Hiroshi ^b   Saito, Takao ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Anemia; Diabetic nephrosclerosis; Hypertension; Renal prognosis and survival

Indexed keywords

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BIOPSY; BLOOD PRESSURE; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; KIDNEY; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 70349680980     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-009-0191-5     Document Type: Article

References (45)

1. The statistic analyzed commission of Japan Society for Dialysis therapy: an overview of dialysis treatment in Japan (as of December 31, 2002).
2. AG Bertoni JK Kirk DC Goff Jr LE Wagenknecht 2004 Excess mortality related to diabetes mellitus in elderly Medicare beneficiaries Ann Epidemiol 14 5 362 367 15177276 10.1016/j.annepidem.2003.09.004 (Pubitemid 38737329)
3. P De Groote N Lamblin F Mouquet D Plichon E Mcfadden E Van Belle, et al. 2004 Impact of diabetes mellitus on long-term survival in patients with congestive heart failure Eur Heart J 25 8 656 662 15084370 10.1016/j.ehj.2004. 01.010 (Pubitemid 38579494)
4. W Otter s Kleybrink W Doering E Standl O Schnell 2004 Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus Diabet Med 21 2 183 187 14984455 10.1111/j.1464-5491.2004.01114.x 1:STN:280:DC%2BD2c%2FpsFarsQ%3D%3D (Pubitemid 38221819)
5. N Hoffart AR Nissenson 1988 The future of end-stage renal disease care: nephrology enters a new millennium Adv Ren Replace Ther 5 257 266
6. H Lee B Manns K Taub WA Ghali S Dean D Johnson, et al. 2002 Cost analysis of ongoing care of patients with end stage renal disease: the impact of dialysis modality and dialysis access Am J Kidney Dis 40 611 622 12200814 10.1053/ajkd.2002.34924 (Pubitemid 34971291)
7. Y Ohkubo H Kishikawa E Araki T Miyata S Isami S Motoyoshi, et al. 1995 Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: randamized prospective 6-year study Diabetes Res Clin Pract 28 103 117 7587918 10.1016/0168-8227(95)01064-K 1:CAS:528:DyaK2MXpsVWgtrs%3D
8. P Fioretto MW Steffes DE Sutherland FC Goetz M Mauer 1998 Reversal of lesions of diabetic nephropathy after pancreas transplantation N Engl J Med 339 69 75 9654536 10.1056/NEJM199807093390202 1:STN:280:DyaK1czgslKhsA%3D%3D (Pubitemid 28304880)
9. P Hovind P Rossing L Tarnow UM Smidt HH Parving 2001 Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively Kidney Int 60 277 283 11422762 10.1046/j.1523-1755.2001. 00797.x 1:STN:280:DC%2BD3Mzmt1Oquw%3D%3D (Pubitemid 32587565)
10. American Diabetes Association: treatment of hypertension in adults with diabetes. Diabetes Care. 2002;25(Suppl 1):S71-S73.
11. S Inomata M Itoh H Imai T Sato 1997 Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy Nephron 75 426 430 9127329 10.1159/000189580 1:CAS:528:DyaK2sXis1KrsLc%3D
12. WF Keane BM Brenner D de Zeeuw JP Grunfeld J McGill WE Mitch, et al. 2003 The risk of developing end stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL Study Kidney Int 63 1499 1507 12631367 10.1046/j.1523-1755.2003.00885.x (Pubitemid 36350016)
13. HP Hansen E Tauber-Lassen BR Jensen HH Parving 2002 Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy Kidney Int 62 1 202 228 10.1046/j.1523-1755.2002.00421.x (Pubitemid 34754065)
14. G Remuzzi A Schieppati P Ruggenenti 2002 Nephropathy in patients with type 2 diabetes N Engl J Med 346 1145 1151 11948275 10.1056/NEJMcp011773 (Pubitemid 34984606)
15. T Narita J Koshimura K Suzuki M Murata H Meguro H Fujita, et al. 1999 Effects of short-term glycemic control, low protein diet and administration of enalapril on renal hemodynamics and protein permselectivity in type 2 diabetic patients with microalbuminuria Tohoku J Exp Med 189 2 117 133 10775055 10.1620/tjem.189.117 1:CAS:528:DC%2BD3cXhtVWkt7o%3D
16. MV Shestakova LA Chugunova MSh Shamkhalova IuA Dirochka II Dedov 1999 Diabetic nephropathy: risk factors of rapid progression of renal failure Ter Arkh 71 6 45 49 10420456 1:STN:280:DyaK1MzkvV2nsw%3D%3D
17. T Furuta T Saito T Ootaka J Soma K Obara K Abe, et al. 1993 The role of macrophages in diabetic glomerulosclerosis AJKD 21 480 485 8488815 1:STN:280:DyaK3s3ls1Sntw%3D%3D
18. DD Gellman DL Dirani JF Soothill RC Muehrcke RM Kark 1959 Diabetic nephropathy: a clinical and pathologic study based on renal biopsies Medicine 38 321 367 13827229 1:STN:280:DyaF3c7kslOiuw%3D%3D
19. Sasatomi Y, Sato H, Chiba Y, Abe Y, Takeda S, Ogahara S, et al. Prognostic factors for renal amyloidosis: a clinicopathological study using cluster analysis. Int Med. 2007;46:213-219.
20. UK prospective Diabetes study Group: tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998; 317:703-713.
21. Heart Outcomes Prevention Evaluation (HOPE) study investigators: effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-259.
22. L Hansson A Zanchetti SG Carruthers B Dahlof D Elmfeldt S Julius, et al. 1998 Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. HOT Study Group Lancet 351 1755 1762 9635947 10.1016/S0140-6736(98)04311-6 1:CAS:528:DyaK1cXksV2qtrY%3D (Pubitemid 28269185)
23. LG Hunsicker S Adler A Caggiula BK England T Greene JW Kusek, et al. 1997 Predictors of the progression of renal disease study Kidney Int 51 1908 1919 9186882 10.1038/ki.1997.260 1:STN:280:DyaK2szjtVChsQ%3D%3D
24. O Samuelsson 1998 Complex apolipoprotein-B containing lipoprotein particles are associated with a high rate of progression of human progressive renal insufficiency J Am Soc Nephrol 9 1482 1488 9697671 1:CAS:528: DyaK1cXltleiur0%3D
25. M Tozawa K Iseki C Iseki S Oshiro Y Ikemiya S Takishita 2002 Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria Kidney Int 62 5 1743 1749 12371975 10.1046/j.1523-1755.2002.00626.x 1:CAS:528:DC%2BD38Xos1ekt7o%3D (Pubitemid 35286282)
26. H Mulec SA Johnsen O Wiklund S Bjorck 1993 Cholesterol: a renal risk factor in diabetic nephropathy? Am J Kidney Dis 22 1 196 201 8322783 1:STN:280:DyaK3szhtFChug%3D%3D
27. D Ellis C Lloyd DJ Becker KY Forrest TJ Orchard 1996 The changing course of diabetic nephropathy: low density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria Am J Kidney Dis 27 809 818 8651245 10.1016/S0272-6386(96)90518-1 1:STN:280:DyaK283jtl2msQ%3D%3D
28. JM Olefsky JW Farquhar GM Reaven 1974 Reappraisal of the role of insulin in hypertriglyceridemia AM J Med 57 551 560 4372881 10.1016/0002-9343(74)90006-0 1:CAS:528:DyaE2MXktFGhtw%3D%3D
29. T Pollar B Vessby H Lithell 1991 Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity Arterioscler Thromb 11 1192 1203
30. A Yildiz M Hursit AV Celik SM Kayacan H Yazici V Akkaya, et al. 2002 Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study Clin Nephrol 58 6 405 410 12508961 1:CAS:528:DC%2BD3sXhsFaisr0%3D
31. N Harada E Takishita N Ishimura A Minami S Sakamoto Y Nakaya 2002 Combined effect of ACE inhibitor and exercise training on insulin resistance In type 2 diabetic rats Life Sci 70 15 1811 1820 12002525 10.1016/S0024-3205(02) 01495-9 1:CAS:528:DC%2BD38XivFKms7k%3D (Pubitemid 34178366)
32. Y Suzuki M Ueno H Hayashi S Nishi H Satou R Karasawa, et al. 1994 A light microscopic study of glomerulosclerosis in Japanese patients with noninsulin-dependent diabetes mellitus: the relationship between clinical and histological features Clin Nephrol 42 3 155 162 7994933 1:STN:280: DyaK2M%2Foslanuw%3D%3D
33. YS Yun HC Lee NC Yoo YD Song SK Lim KR Kim, et al. 1999 Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy Diabetes Res Clin Pract 46 223 229 10624788 10.1016/S0168-8227(99)00097-2 1:CAS:528:DyaK1MXntlentrg%3D
34. DR Bosman AS Winkler JT Marsden IC Macdougall PJ Watkins 2001 Anemia with erythropoietin deficiency occurs early in diabetic nephropathy Diabetes Care 24 495 499 11289474 10.2337/diacare.24.3.495 1:STN:280:DC%2BD3M7pslCmug%3D%3D
35. AS Winkler J Marsden KR Chaudhuri H Mambley PJ Watkins 1999 Erythropoietin depletion and anemia in diabetes mellitus Diabet Med 16 813 819 10547207 10.1046/j.1464-5491.1999.00172.x 1:STN:280:DC%2BD3c%2Fht1Kqug%3D%3D (Pubitemid 29498219)
36. B Bayes A Serra J Junca R Lauzurica 1998 Successful treatment of anemia of nephrotic syndrome with recombinant human erythropoietin Nephrol Dial Transplant 13 1894 1895 9681764 10.1093/ndt/13.7.1895 1:STN:280: DyaK1czksFSruw%3D%3D (Pubitemid 28306848)
37. LM Laffel JB McGill DJ Ganx 1995 The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria Am J Med 99 497 504 7485207 10.1016/S0002-9343(99)80226-5 1:CAS:528:DyaK28XktV2gsA%3D%3D
38. The microalbuminuria Captopril Study Group: captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia. 1996;39:587-593.
39. EJ Lewis LG Hunsicker RP Bain RD Rohde 1993 The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1456 1462 8413456 10.1056/NEJM199311113292004 1:STN:280: DyaK2c%2FhvFKitQ%3D%3D (Pubitemid 23335891)
40. HH Parving H Lehnert J Brochner-Mortensen R Gomis S Andersen P Arner 2001 The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 870 878 11565519 10.1056/NEJMoa011489 1:CAS:528:DC%2BD3MXntlelsLY%3D (Pubitemid 34940826)
41. EJ Lewis LG Hunsicker WR Clarke T Berl MA Pohl JB Lewis, et al. 2001 Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 851 860 11565517 10.1056/NEJMoa011303 1:CAS:528:DC%2BD3MXntlelsLg%3D (Pubitemid 34940824)
42. BM Brenner ME Cooper D de Zeeuw WF Keane WE Mitch HH Parving, et al. 2001 Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 861 869 11565518 10.1056/NEJMoa011161 1:CAS:528:DC%2BD3MXntlelsLk%3D (Pubitemid 34940825)
43. F Locatelli RL Pisoni C Combe J Bommer VE Andreucci L Piera, et al. 2004 Anemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns study (DOPPS) Nephrol dial Transplant 19 121 132 14671047 10.1093/ndt/gfg458 (Pubitemid 38072623)
44. F Licatelli RL Pisoni JL Bragg 2002 Higher hemoglobin levels are associated with lower rates of mortality and hospitalization among European hemodialysis patients: results from the DOPPS Nephrol Dial Transplant 17 S-1 23
45. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837 853 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)